FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to ...
One main concern is to what extent insurance providers will cover such a drug, given the abundance of cheaper alternatives. The FDA has already approved more than a dozen antipsychotics for ...
The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...
Even though there is no official Ozempic Diet, there are certain foods you can avoid to minimize your chances of negative ...
Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay ...
The agency approved the emergency use of the Alinity m MPXV assay, manufactured by Abbott Molecular (NYSE:ABT), as an important step in improving global access to mpox testing. The Alinity m MPXV ...
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
The poisonous flower yellow oleander is showing up in diet ... Drug Administration. Consuming yellow oleander can cause heart and brain problems that can be severe or even deadly. The FDA said ...
A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...
The US FDA has approved Bristol ... beginning with today’s approval for schizophrenia.” Bristol Myers Squibb plans to make Cobenfy, a twice-daily pill, available by late October.
The U.S. Food and Drug Administration (FDA) approved a novel antipsychotic schizophrenia drug late Thursday, marking the first new treatment in decades for the mental health condition that affects ...
No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA ... in-class, best-in-category ...